Redenlab ataxia experience

box-icon

Sites

40

box-icon

Patients

500

box-icon

Languages

14

box-icon

Clinical trials

10+

box-icon

Natural history studies

10+

    Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
      Redenlab’s CEO, Adam Vogel, co-wrote "The Role of Verbal Fluency in the Cerebellar Cognitive Affective Syndrome Scale in Friedreich Ataxia"...
        Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination difficulties. SCA1...

          A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the development of digital health technologies (DHTs) tailored to the needs of individuals with frontotemporal degeneration (FTD).

            A recent study published in iScience explores the effects of KAT6B overexpression in mice, shedding light on the behavioral implications...
              Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss of speech, language, and...